한글목차

골이식 및 뼈 대체재 시장은 2026년에 44억 달러로 추정되며, 2033년까지 66억 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 6.9%를 나타낼 전망입니다.

뼈 이식의 결합은 기증자의 뼈 조직과 수혜자(이식 대상자)에 침착된 새로운 뼈가 서로 맞물리고 감싸는 과정으로 정의할 수 있습니다. 이는 손실된 뼈 조직을 대체하고 자연적 메커니즘을 이용하여 뼈의 성장을 가속하는 다재다능한 방법입니다. 천연골 이식편은 가장 성공률이 높은 뼈 이식법으로, 결손된 뼈를 대체할 수 있는 골드 스탠다드로 여겨지고 있습니다. 뼈 이식은 낭종이나 종양 등으로 인한 공동 충진, 초기 치료 후 치유되지 않은 골절의 치유 촉진 등 다양한 목적으로 사용됩니다.

시장 역학

"Journal of Materials Science and Materials in Medicine(2014)에 따르면, 뼈 이식은 수혈에 이어 세계에서 두 번째로 많이 시행되는 조직 이식 기술입니다. 이 잡지가 보고한 2014년 통계에 따르면, 연간 200만 건 이상의 뼈 이식 수술이 이루어지고 있으며, 미국에서만 50만 건 이상의 이식 임플란트 수술이 이루어지고 있습니다. 이는 새로운 장치의 사용 및 취급 용이성, 향상된 안전성 프로파일, 시간적 이점, 수술 중 비용 및 다양한 임상적 과제에 대한 적응성 때문인 것으로 분석됩니다.

세계 골이식 및 골대체재 시장은 예측 기간 동안 괄목할 만한 성장이 예상됩니다. 이는 제조업체들이 혁신적이고 새로운 뼈 이식 대체재 개발을 위해 새로운 기술을 채택하고 있기 때문입니다. 여기에는 수술 후 회복 측면에서 이식재의 품질을 향상시키는 신규 성장인자 강화 이식재 출시도 포함됩니다. 예를 들어, 2015년에는 비상장사인 세라펙스가 경추 추간판 절제술 및 고정술에 사용되는 펩타이드 강화 이식재 'i-Factor'에 대해 미국 FDA의 승인을 받았습니다. 이 이식재는 세포의 부착과 활성화를 통해 뼈의 성장을 돕는 소분자 펩타이드(P-15) 기술을 기반으로 합니다.

본 조사의 주요 특징

• 이 보고서는 2018년을 기준 연도로 하여 예측 기간(2019-2027)의 세계 뼈 이식 및 뼈 대체재 시장에 대한 상세한 분석을 제공합니다.
• 각 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
• 시장 성장 촉진요인, 억제요인, 기회, 신기술 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
• 이 보고서는 기업 개요, 재무 성과, 기술 포트폴리오, 지리적 입지, 유통 전략, 주요 개발 및 전략과 같은 매개 변수를 기반으로 세계 골 이식 및 골 대체재 시장의 주요 업체를 프로파일링합니다.
• 이 보고서는 기업의 마케팅 담당자와 경영진이 향후 기술 투입, 정부 정책, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
• 이 세계 뼈 이식 및 뼈 대체재 시장 보고서는 투자자, 기술 제조업체, 유통업체, 공급업체, 연구 및 컨설팅 회사, 신규 시장 진출기업, 재무 분석가 등 이 시장의 다양한 이해관계자에게 유용한 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 범위

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 골이식 및 뼈 대체재 시장 : 제품 유형별, 2026-2033년

제5장 세계의 골이식 및 뼈 대체재 시장 : 용도별, 2026-2033년

제6장 세계의 골이식 및 뼈 대체재 시장 : 지역별, 2026-2033년

제7장 경쟁 구도

제8장 애널리스트 추천 사항

제9장 섹션

영문목차

Bone Graft And Substitutes Market is estimated to be valued at USD 4.40 Bn in 2026 and is expected to reach USD 6.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

The incorporation of a bone graft can be defined as a procedure of interdigitation and envelopment of the donor bone tissue with the new bone deposited by the recipient. It is a versatile that replaces the lost bone tissue, enhances bone growth using natural mechanisms. The natural bone graft are the most successful types of bone grafts and are considered to be the gold standard for replacement of missing bones. Bone grafts are in used in various purposes such as to fill the cavities resulting from cysts, tumors, or other causes, to stimulate the healing of fractures that have failed to heal after an initial treatment attempt, and others.

Market Dynamics

According to the Journal of Materials Science and Materials in Medicine, 2014, bone grafting frequency is the second most frequent tissue transplantation technique carried out globally after blood transfusion. The 2014 statistics reported in the Journal of Materials Science and Materials in Medicine, states that over 2 million bone grafting procedures are performed annually with over 500,000 graft implant procedures carried out in the U.S. itself. This is attributed to the ease of use and handling of new devices, improved safety profile, time advantages, intraoperative costs as well as the adaptability to a variety of clinical challenges.

The global bone graft, substitutes and membrane market is expected to witness a significant growth over the forecast period, owing to adoption of new technologies by manufacturers for development of innovative and novel bone graft substitutes. This includes the launches of novel growth factor enhanced grafts that improves the quality of grafts in terms of post-surgical recovery. For instance, in 2015, Cerapedics, a privately owned orthobiologics company received the U.S. FDA approval for i-Factor, which is a peptide enhanced graft that is used in cervical discectomy and fusion. The graft was based on small peptide (P-15) technology that helps in supporting bone growth through cell attachment and activation

Key features of the study

• This report provides in-depth analysis of the global bone graft and substitutes market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019-2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global bone graft and substitutes market based on the following parameters - company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Ace Surgical Supply Co., Inc., NovaBone Product, LLC., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation., BioHorizons Implant Systems, Inc., Globus Medical, Inc., RTI Surgical, Inc., Geistlich Pharma, Megagen, Novadip Biosciences, Mesoblast Ltd., Alphatec Spine, Inc., Institut Straumann AG, NuVasive, Inc., OsteoMed LLC, KYERON Medical Innovations, ORTHOFIX INTERNATIONAL N.V., Johnson & Johnson, Bone Therapeutics SA, K2M Group Holdings, Inc., and OsteoNovus
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
• The global bone graft and substitutes market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global bone graft and substitutes market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• By Product Type
  • Bone Grafts
  • Allografts
  • Xenografts
  • Bone Graft Substitutes
  • Ceramics
  • Composites
  • Polymers
  • Demineralized Bone Matrix
  • Bone Morphogenetic Proteins
  • Others
• By Application
  • Spinal Fusion
  • Dental Bone Grafts
  • Craniomaxillofacial
  • Joint Reconstruction
  • Trauma & Extremities
  • Oncology
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Ace Surgical Supply Co., Inc.
  • NovaBone Product, LLC.
  • Exactech, Inc.
  • Medtronic Plc.
  • LifeNet Health
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation.
  • BioHorizons Implant Systems, Inc.
  • Globus Medical, Inc.
  • RTI Surgical, Inc.
  • Geistlich Pharma
  • Megagen
  • Novadip Biosciences
  • Mesoblast Ltd.
  • Alphatec Spine, Inc.
  • Institut Straumann AG
  • NuVasive, Inc.
  • OsteoMed LLC
  • KYERON Medical Innovations
  • ORTHOFIX INTERNATIONAL N.V.
  • Johnson & Johnson
  • Bone Therapeutics SA
  • K2M Group Holdings, Inc.
  • OsteoNovus

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Bone Graft And Substitutes Market, By Product Type, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Bone Grafts
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Allografts
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Xenografts
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Bone Graft Substitutes
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Ceramics
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Composites
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Polymers
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Demineralized Bone Matrix
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Bone Morphogenetic Proteins
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Bone Graft And Substitutes Market, By Application, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Spinal Fusion
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Dental Bone Graft
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Craniomaxillofacial
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Joint Reconstruction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Trauma & Extremities
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oncology
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Bone Graft And Substitutes Market, By Region, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Ace Surgical Supply Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
    • NovaBone Product, LLC.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Exactech, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
    • Medtronic Plc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • LifeNet Health
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Zimmer Biomet Holdings, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Stryker Corporation
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • BioHorizons Implant Systems, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Globus Medical, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • RTI Surgical, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Geistlich Pharma
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Megagen
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Novadip Biosciences
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Mesoblast Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Alphatec Spine, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Institut Straumann AG
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • NuVasive, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • OsteoMed LLC
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • KYERON Medical Innovations
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • ORTHOFIX INTERNATIONAL N.V.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Johnson & Johnson
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Bone Therapeutics SA
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • K2M Group Holdings, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • OsteoNovus
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

8. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. Section

• References
• Research Methodology
• About Us and Sales Contact